Literature DB >> 22862941

Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.

Craig J Taylor1, Sarah Peacock, Afzal N Chaudhry, J Andrew Bradley, Eleanor M Bolton.   

Abstract

The likelihood for immunological rejection of Human Leukocyte Antigens (HLA)-mismatched induced pluripotent stem cells (iPSCs) limits their therapeutic potential. Here we show how a tissue bank from 150 selected homozygous HLA-typed volunteers could match 93% of the UK population with a minimal requirement for immunosuppression. Our model provides a practical approach for using existing HLA-typed samples to generate an iPSC stem cell bank that circumvents prospective typing of a large number of individuals.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862941     DOI: 10.1016/j.stem.2012.07.014

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  151 in total

Review 1.  Tissue Engineering and Regenerative Medicine 2015: A Year in Review.

Authors:  Holly Wobma; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2016-02-23       Impact factor: 6.389

Review 2.  Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.

Authors:  Johanna Erbani; Daniel Aberdam; Jerome Larghero; Valérie Vanneaux
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

Review 3.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 4.  The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.

Authors:  Zachary S Scheiner; Sohel Talib; Ellen G Feigal
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 5.  Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.

Authors:  Zhengping Jiang; Yanmei Han; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2013-12-16       Impact factor: 11.530

6.  NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells.

Authors:  Akhilesh Kumar; Jeong Hee Lee; Kran Suknuntha; Saritha S D'Souza; Abir S Thakur; Igor I Slukvin
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

Review 7.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 8.  Methods of induced pluripotent stem cells for clinical application.

Authors:  Tomohisa Seki; Keiichi Fukuda
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

9.  The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.

Authors:  Xiaomeng Hu; Simon T Kueppers; Nigel G Kooreman; Alessia Gravina; Dong Wang; Grigol Tediashvili; Stephan Schlickeiser; Marco Frentsch; Christos Nikolaou; Andreas Thiel; Sivan Marcus; Sigrid Fuchs; Joachim Velden; Hermann Reichenspurner; Hans-Dieter Volk; Tobias Deuse; Sonja Schrepfer
Journal:  Stem Cells Dev       Date:  2020-08-25       Impact factor: 3.272

Review 10.  Myocardial Tissue Engineering for Regenerative Applications.

Authors:  Buntaro Fujita; Wolfram-Hubertus Zimmermann
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.